TARS Tarsus Pharmaceuticals, Inc.
$71.76▲ +1.41%
Healthcare
Other
Volume 136.3K
Avg Volume (10D) 1.08M
Key Metrics & Fundamentals
Market Cap
$3.36B
P/E Ratio
–
Div Yield
0.00%
52W Range
53.89 - 91.53
% vs 50 MA
-5.73%
% vs 200 MA
4.35%
RSI-14
46.1
MACD Histogram
-0.1400
Beta (1Y vs SPY)
0.65
Free Cash Flow
$57.15M
Gross Rev
$173.91M
Gross Profit
$161.80M
EBITDA
-$15.66M
COGS
$12.11M
Operating Exp
$181.71M
Operating Income
-$19.91M
EBIT
-$19.91M
Pretax Income
-$15.84M
Net Income
-$18.55M
EPS (Diluted)
-0.43
Price & Volume History
Loading chart…
Recent News
Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth
Zacks · Oct 28, 2026 9:00 AM ET
Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer
GlobeNewswire · Oct 28, 2026 8:30 AM ET
Earnings Preview: Tarsus Pharmaceuticals, Inc. (TARS) Q3 Earnings Expected to Decline
Zacks · Oct 27, 2026 9:00 AM ET
What First Trust NYSE Arca Biotech (FBT) Bought: Tarsus Leads on Oct. 16
GuruFocus.com · Oct 20, 2026 7:04 AM ET
ETFs Are Net Sellers of Tarsus Pharmaceuticals (TARS) on Oct. 16
GuruFocus.com · Oct 20, 2026 7:01 AM ET
Lisata adds biopharma finance veteran Jeffrey Farrow to board
Proactive · Oct 15, 2026 8:41 AM ET
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
GlobeNewswire · Oct 14, 2026 4:05 PM ET
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
GlobeNewswire · Sep 29, 2026 8:30 AM ET
When To Dump Stocks: These IBD 50 Components Hit Sell Signals
Investor's Business Daily · Sep 18, 2026 12:56 PM ET
Tarsus Pharmaceuticals Insider Sold Shares Worth $979,744, According to a Recent SEC Filing
MT Newswires · Sep 17, 2026 4:34 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TARS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.